Patent Assignment
Reel/Frame 051181/0038
Assignment of Assignor's Interest
Recorded: 2019-12-04
Pages: 22
Assignor
CELGENE CORPORATION
Executed: 2019-11-21
Assignee
AMGEN INC.
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CALIFORNIA, 91320
Covered Properties
(91)
(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods of Using and Compositions Thereof
Fluoroalkoxy-Substituted 1,3-Dihydro-Isoindolyl Compounds and Their Pharmaceutical Uses
N-Alkyl-Hydroxamic Acid-Isoindolyl Compounds and Their Pharmaceutical Uses
Isoindoline Compounds and Methods of Making and Using the Same
Isoindoline Compounds and Methods of Their Use
(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione:, and Methods of Synthesis and Compositions Thereof
Methods of Using N-Alkyl-Hydroxamic Acid-Isoindolyl Compounds
Methods of Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4 Acetylaminoisoindoline 1,3-Dione
Methods of the Treatment of Psoriatic Arthritis Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione
Methods of the Treatment or Prevention of Exercise-Induced Asthma Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione
Fluoroalkoxy-Substituted 1,3-Dihydro-Isoindolyl Compounds and Their Pharmaceutical Uses
Isoindoline Compounds and Methods of Making and Using the Same
Methods of Using(+)-2-[1-(3-Ethoxy-4METHOXYPHENYL)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3,-Dione
Methods of Using (+)-2-[1-(3-Ethoxy-4 Methoxyphenyl)-2-Methylsulfonylethyl]-4 Acetylaminoisoindoline 1,3-Dione
Isoindoline Compounds and Methods of Their Use
Solid Forms Comprising (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2- Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione, Compositions Thereof, and Uses Thereof
Methods of Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline- 1,3-Dione
Fluoroalkoxy-Substituted 1,3-Dihydro-Isoindolyl Compounds and Their Pharmaceutical Uses
Isoindoline Compounds and Methods of Making and Using the Same
Isoindoline Compounds and Methods of Their Use
Processes for the Preparation of Aminosulfone Compounds
Methods of Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline 1,3-Dione
N-Alkyl-Hydroxamic Acid-Isoindolyl Compounds and Their Pharmaceutical Uses
Nanosuspension of a Poorly Soluble Drug via Microfluidization Process
Solid Forms Comprising (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione, Compositions Thereof, and Uses Thereof
Fluoroalkoxy-Substituted 1,3-Dihydro-Isoindolyl Compounds and Their Pharmaceutical Uses
Biomarkers for the Treatment of Psoriasis
Application:
13/161,201 →
Publication:
US 2011/0318741
Solid Forms Comprising (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione, Compositions Thereof, and Uses Thereof
Phenethylsulfone Isoindoline Derivatives and Their Use
Methods and Compositions Using PDE4 Inhibitors for the Treatment and Management of Autoimmune and Inflammatory Diseases
Methods for Treating Respiratory Viral Infection
Methods of Treating Arthritic Conditions Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline 1,3-Dione
Formulations of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetylaminoisoindoline-1,3-Dione
Application:
13/727,366 →
Publication:
US 2013/0164376
Processes for the Preparation of (S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-Methanesulfonylethylamine
Asymmetric Synthetic Processes for the Preparation of Aminosulfone Compounds
Oral Dosage Forms of Cyclopropanecarboxylic Acid {2-[(1S)-1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-3-Oxo-2,3-Dihydro-1H-Isoindol-4-Yl}-Amide
Isotopologues of Isoindole Derivatives
Controlled Release Oral Dosage Forms of Poorly Soluble Drugs and Uses Thereof
Application:
13/993,046 →
Publication:
US 2014/0018404
Methods for Treating Diseases Using Isoindoline Compounds
Processes for the Preparation of Isoindole Compounds and Isotopologues Thereof
Solid Forms Comprising (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione, Compositions Thereof, and Uses Thereof
Methods for the Treatment of Psoriatic Arthritis Using Apremilast
Formulations of (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione
Methods of Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline 1,3-Dione
Formulations of Cyclopropanecarboxylic Acid {2-[(1S)-1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-3-Oxo-2,3-Dihydro-1H-Isoindol-4-Yl}-Amide
Methods for the Treatment of Obesity Using Apremilast
Application:
14/603,128 →
Publication:
US 2015/0209327
Processes for the Preparation of Isoindole Compounds and Isotopologues Thereof
Solid Forms Comprising (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4- Acetylaminoisoindoline-1,3-Dione, Compositions Thereof, and Uses Thereof
Nanosuspension of a Poorly Soluble Drug via Microfluidization Process
Use of PDE4 Inhibitors and Combinations Thereof for the Treatment of Cystic Fibrosis
Isotopologues of Isoindole Derivatives
Methods for the Treatment of Diseases Ameliorated by PDE4 Inhibition Using Dosage Titration of Apremilast
Processes for the Preparation of (S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-Methanesulfonylethylamine
Controlled Release Oral Dosage Forms of Poorly Soluble Drugs and Uses Thereof
Methods of Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione
Compositions and Methods for the Treatment of Atherosclerotic Cardiovascular Diseases with PDE4 Modulators
Application:
15/311,153 →
Publication:
US 2017/0087129
Apremilast for the Treatment of a Liver Disease or a Liver Function Abnormality
Processes for the Preparation of (S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-Methanesulfonylethylamine
Methods of Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione
Methods for the Treatment of Diseases Ameliorated by PDE4 Inhibition Using Dosage Titration of Apremilast
Application:
16/109,634 →
Publication:
US 2018/0360807
Methods of Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione
Pharmaceutical Tablet
Patent:
735,315 →
Application:
29/425,538 →
Methods of using and compositions comprising an enatiomer of 2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
Application:
60/366,515 →
Methods of using and compositions comprising an enantiomer of 2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
Application:
60/366,516 →
(+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
Application:
60/438,450 →
Processes for the Preparation of Aminosulfone Compounds
Application:
61/095,902 →
Nanosuspension of a Poorly Soluble Drug via Microfluidization Process
Application:
61/259,903 →
Methods for Treating Respiratory Viral Infection
Application:
61/321,802 →
Biomarkers for the Treatment of Psoriasis
Application:
61/355,116 →
Controlled Release Oral Dosage Forms of Poorly Soluble Drugs and Uses Thereof
Application:
61/424,003 →
Phenethylsulfone Isoindoline Derivatives and Their Use
Application:
61/431,350 →
Oral Dosage Forms of Cyclopropanecarboxylic Acid {2-[(1S)-1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-3-Oxo-2,3-Dihydro-1H-Isoindol-4-Yl}-Amide
Application:
61/431,355 →
Isotopologues of Isoindoline Derivatives
Application:
61/433,123 →
Methods for Treating Respiratory Viral Infection
Application:
61/435,726 →
Methods for Treating Diseases Using Isoindoline Compounds
Application:
61/449,716 →
Biomarkers for the Treatment of Psoriasis
Application:
61/454,916 →
Methods and Compositions Using PDE4 Inhibitors for the Treatment and Management of Autoimmune and Inflammatory Diseases
Application:
61/480,263 →
Formulations of Cyclopropanecarboxylic Acid {2-[(1S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-Methanesulfonyl-Ethyl]-3-Oxo-2,3-Dihydro-1H-Isoindol-4-Yl}-Amide
Application:
61/534,841 →
Formulations of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetylaminoisoindoline-1,3-Dione
Application:
61/580,626 →
Processes for the Preparation of (S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-Methanesulfonylethylamine
Application:
61/601,226 →
Asymmetric Synthetic Processes for the Preparation of Aminosulfone Compounds
Application:
61/601,480 →
Asymmetric Synthetic Processes for the Preparation of Aminosulfone Compounds
Application:
61/648,521 →
Processes for the Preparation of Isoindole Compounds and Isotopologues Thereof
Application:
61/701,424 →
Methods for the Treatment of Psoriatic Arthritis Using Apremilast
Application:
61/782,880 →
Formulations of (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione
Application:
61/835,667 →
Formulations of (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione
Application:
61/840,210 →
Methods for the Treatment of Obesity Using Apremilast
Application:
61/931,143 →
Use of PDE4 Inhibitors and Combinations Thereof for the Treatment of Cystic Fibrosis
Application:
61/993,467 →
Compositions and Methods for the Treatment of Atherosclerotic Cardiovascular Diseases with PDE4 Modulators
Application:
61/994,773 →
Methods for the Treatment of Liver Disease or a Liver Function Abnormality Using Apremilast
Application:
62/016,013 →
Methods for the Treatment of Diseases Ameliorated by PDE4 Inhibition Using Dosage Titration of Apremilast
Application:
62/038,176 →
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 19, 2003
From: SCHAFER, PETER W.; MULLER, GEORGE W.; MAN, HON-WAH; GE, CHUANSHENG
To: CELGENE CORPORATION
Reel/Frame 014452/0476 →
Assignment of Assignor's Interest
Jun 11, 2004
From: MULLER, GEORG W.; MAN, HON WAH; ZHANG, WEIHONG
To: CELGENE CORPORATION
Reel/Frame 015455/0808 →
Assignment of Assignor's Interest
Nov 23, 2004
From: MULLER, GEORGE W.; MAN, HON-WAH
To: CELGENE CORPORATION
Reel/Frame 016018/0184 →
Assignment of Assignor's Interest
Nov 23, 2004
From: MULLER, GOERGE W.; MAN, HON-WAH
To: CELGENE CORPORATION
Reel/Frame 016018/0203 →
Assignment of Assignor's Interest
Apr 26, 2006
From: MULLER, GEORGE; SCHAFER, PETER; ROHANE, PATRICIA
To: CELEGENE CORPORATION
Reel/Frame 017820/0243 →
Assignment of Assignor's Interest
Apr 26, 2006
From: MULLER, GEORGE; SCHAFER, PETER; ROHANE, PATRICIA
To: CELGENE CORPORATION
Reel/Frame 017820/0265 →
Assignment of Assignor's Interest
Feb 8, 2008
From: MULLER, GEORGE W.; SCHAFER, PETER H.; MAN, HON-WAH; GE, CHUANSHENG
To: CELGENE CORPORATION
Reel/Frame 020545/0166 →
Assignment of Assignor's Interest
Feb 15, 2008
From: MULLER, GEORGE W.; MAN, HON WAH
To: CELGENE CORPORATION
Reel/Frame 020583/0996 →
Assignment of Assignor's Interest
Apr 10, 2008
From: MULLER, GEORGE W.; SCHAFER, PETER H.; MAN, HON-WAH; GE, CHUANSHENG
To: CELGENE CORPORATION
Reel/Frame 020785/0923 →
Assignment of Assignor's Interest
Apr 15, 2008
From: MULLER, GEORGE W.; SCHAFER, PETER H.; MAN, HON-WAH; GE, CHUANSHENG
To: CELGENE CORPORATION
Reel/Frame 020836/0596 →
Assignment of Assignor's Interest
Apr 15, 2008
From: MULLER, GEORGE W.; SCHAFER, PETER H.; MAN, HON-WAH; GE, CHUANSHENG
To: CELGENE CORPORATION
Reel/Frame 020822/0792 →
Assignment of Assignor's Interest
Apr 15, 2008
From: MULLER, GEORGE W.; SCHAFER, PETER H.; MAN, HON-WAH; GE, CHUANSHENG
To: CELGENE CORPORATION
Reel/Frame 020822/0827 →
Assignment of Assignor's Interest
Apr 15, 2008
From: MULLER, GEORGE W.; SCHAFER, PETER H.; MAN, HON-WAH; GE, CHUANSHENG
To: CELGENE CORPORATION
Reel/Frame 020825/0214 →
Assignment of Assignor's Interest
Jun 9, 2008
From: MULLER, GEORGE W.; SCHAFER, PETER H.; MAN, HON-WAH; GE, CHUANSHENG
To: CELGENE CORPORATION
Reel/Frame 021103/0728 →
Assignment of Assignor's Interest
Jun 30, 2011
From: MAN, HON-WAH; MULLER, GEORGE W.
To: CELGENE CORPORATION
Reel/Frame 026533/0090 →